IL1B and rheumatoid arthritis: Recombinant IL-1RA is FDA approved for rheumatoid arthritis, in which IL-1β is increased two-fold in plasma [42] and 100-fold in synovial [43] fluid compared to individuals without rheumatoid arthritis.